Pay in 4 interest-free payments of $8.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
InChiKey: UJQGBYRKCZQJJS-UHFFFAOYSA-N
Tyler Lahusen
placebo-controlled clinical trial was designed to evaluate the safety
Saturday G
ETC-159 - CAS# 1638250-96-0 210 InChiKey: UJQGBYRKCZQJJS-UHFFFAOYSA-NETC 159, CAS No. 1638250 96 0, also known as ETC 1922159, is a potent, selective and orally available PORCN inhibitor. ETC 159 blocks the secretion and activity of all Wnts. ETC 159 is remarkably effective in treating RSPO translocation bearing colorectal cancer (CRC) patient derived xenografts. Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers. Enhanced sensitivity to Wnts is
US$ 65.00
US$ 142.00
US$ 32.99
US$ 109.99
US$ 17.99
US$ 12.97
US$ 15.99
US$ 11.99
US$ 49.99
US$ 12.83
US$ 19.89
US$ 29.99
US$ 24.99
US$ 44.99
US$ 19.01
US$ 29.99
US$ 12.99
US$ 19.89
US$ 24.20
US$ 24.20